All Posts Tagged With: "DXCM"
(DXCM) DexCom Misses Analyst Estimates
DexCom (DXCM), a prominent player in the glucose monitoring market, reported first-quarter fiscal 2011 loss per share of 19 cents, a penny higher than the Zacks Consensus Estimate while sharply less than...
(DXCM) DexCom Earnings Report Meets The Street but Sales Miss
DexCom (DXCM) reported third-quarter 2010 loss per share of 23 cents, matching the Zacks Consensus Estimate and improving from the year-ago loss of 29 cents.
Revenues
Total...
(DXCM) DexCom Analyst Reiterates Stock at Neutral
We reaffirm our Neutral recommendation on DexCom Inc (DXCM), a prominent player in the continuous glucose monitoring market. Second-quarter fiscal 2010 loss per share of 20 cents matched the Zacks Consensus...
(DXCM) DexCom Quarterly Loss Higher Than Expected
DexCom, Inc. (DXCM) reported a loss of 27 cents per share in the first quarter, 3 cents above the Zacks Consensus Estimate of a loss of 24 cents but well below the year-ago loss of 33 cents.
Revenues...
(DXCM) DexCom Reports Smaller Loss on Increased Revenues
DexCom, Inc. (DXCM) reported a net loss of 25 cents per share in the fourth quarter of 2009, a couple cents narrower than the Zacks Consensus Estimate for a net loss of 27 cents and significantly narrower...
(DXCM) DexCom SEC Filing Reports Product Revenues
In a filing with the U.S. Securities and Exchange Commission (SEC), DexCom, Inc. (DXCM) recently stated that it expects unaudited product revenues of approximately $6.6 million for the fourth quarter of 2009....
(DXCM) DexCom Incorporated’s Loss Narrows
DexCom, Inc. (DXCM) reported a net loss of 29 cents per share in the third quarter, 3 cents below the Zacks Consensus Estimate of a net loss of 32 cents and significantly below the year-ago net loss of 53...